Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1.
Pharmaceutics
; 14(8)2022 Aug 09.
Article
in En
| MEDLINE
| ID: mdl-36015287
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmaceutics
Year:
2022
Document type:
Article
Country of publication: